Join biomodal, along with leading minds in science and industry for two days of cutting-edge insights into NGS and omics technologies. Whether you manage a core facility, are a seasoned NGS user, or a researcher eager to explore the latest in genomics, this summit offers a rich program of expert talks, networking opportunities.
Large diagnostic laboratory adopts 6-base sequencing to improve disease characterisation
The Munich Leukaemia Laboratory (MLL) are investigating the role of the 6-base genome to develop workfows that enable the detection of epigenetic patterns in leukemia patients.
